openPR Logo
Press release

he Worldwide Pharmaceutical Market Forecasts To 2018

11-28-2016 10:19 AM CET | Health & Medicine

Press release from: Pharmaceutical Market

This analysis report is an essential resource for business forecasters, marketing planners, the investment community and anyone looking to understand the future outlook for the dynamic pharmaceutical industry. With this report you have instant access to thousands of market projections and ranking to inform and direct your future operations.

The report, compiled by Espicom’s pharmaceutical market experts with 30 years’ experience in the industry, provides you with global, regional and national views on the worldwide pharmaceutical market to reveal key insights into the future outlook:

A global overview of key rankings

Five regional sections allowing comparative assessment of countries within a geographic region: • Americas • Asia/Pacific • Central/Eastern Europe • Middle East/Africa • Western Europe
Individual country markets providing detail and forecasts at a national level
Extensive forecasts for key pharmaceutical product areas

For each individual country market the report gives you the following data for 2009-2018, allowing you to compare and contrast performance and prospects:

Basic economic and demographic data
Pharmaceutical market by category (US$ millions)
Pharmaceutical market by category per capita (US$)
Pharmaceutical market by category (% of total)

Download Sample Copy of Report at http://www.marketresearchreports.biz/sample/sample/173586

Global listings

The report contains a range of listings by key economic and market indicators, listed globally and by region and country, allowing you to benchmark and cross reference by key statistics:

World summary: Total pharmaceutical market by category (US$ billions)
Pharmaceutical sales (US$ bn)
Pharmaceutical sales (EUR bn)
Pharmaceutical sales, per capita (US$)
Pharmaceutical sales, % of GDP
Pharmaceutical sales, % of health expenditure
Prescription drug sales (US$ bn)
Prescription drug sales (EUR bn)
Prescription drug sales, per capita (US$)
Prescription drug sales, % of GDP
Prescription drug sales, % of total sales
Patented drug sales (US$ bn)
Patented drug sales (EUR bn)
Patented drug sales, per capita, (US$)
Patented drug sales, % of prescription sales
Patented drug sales, % of total sales
Generic drug sales (US$ bn)
Generic drug sales (EUR bn)
Generic drug sales, per capita, (US$)
Generic drug sales, % of prescription sales
Generic drug sales, % of total sales
Over-the-counter (OTC) medicine sales (US$ bn)
Over-the-counter (OTC) medicine sales (EUR bn)
Over-the-counter (OTC) medicine sales, per capita, (US$)
Over-the-counter (OTC) medicine sales, % of GDP
Over-the-counter (OTC) medicine sales, % of total sales
World summary: Total healthcare market by category (US$ billions)
Health expenditure (US$ bn)
Health expenditure (EUR bn)
Health expenditure, per capita, (US$)
Total health expenditure by country as % of GDP, 2009-18
Government health expenditure (US$ bn)
Government health expenditure (EUR bn)
Government health expenditure, % of GDP
Government health expenditure, % total health expenditure
Private health expenditure (US$ bn)
Private health expenditure (EUR bn)
Private health expenditure, % of GDP
Private health expenditure, % total health expenditure
GDP by country, 2009-18 (US$ billions)
GDP per capita by country 2009-18 (US$)
Population by country, 2009-18 (millions)
Population by country, 2009-18 (millions)

For each region

Pharma by market
Health expenditure by market
GDP per country (US$ billions)
GDP per capita (US$)
Population by country, 2009-18 (millions)
Population by country, 2009-18 (% of total)

For each country

Basic data
Pharma data

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
Email: sales@marketresearchreports.biz

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release he Worldwide Pharmaceutical Market Forecasts To 2018 here

News-ID: 387722 • Views:

More Releases from Pharmaceutical Market

The Mid-Size Pharmaceutical Market to 2023| Wilo, Pentair, KSB, Ebara, HCP, ITT, Sanofi-Aventis, Pharmaceutical Enterprises, PharmaProduct Manufacturing
The Mid-Size Pharmaceutical Market to 2023| Wilo, Pentair, KSB, Ebara, HCP, ITT, …
Albany, NY, 21st January : Recent research and the current scenario as well as future market potential of "Global Pharmaceutical Market Insights, Forecast to 2025" globally. GBI Research’s latest report, The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players, provides an in-depth assessment of the current trends in the global mid-size pharma market, along with growth strategies being pursued by these companies. Get PDF for more Professional

More Releases for GDP

China's GDP Surprises on Buoyant Demand
Economists are becoming more positive on this year's economic prospects. Image: https://www.getnews.info/uploads/00fca63e211ffb8a1956472d8f5965db.jpg In its April World Economic Outlook (WEO), the IMF now forecasts aggregate GDP growth to reach 3.2 percent this year, up 0.3 percentage points from its October projection. The Fund describes the global economy as "surprisingly resilient [https://www.imf.org/en/Publications/WEO/Issues/2024/04/16/world-economic-outlook-april-2024?cid=ca-com-homepage-SM2024]" for the way in which it has continued to grow despite the higher interest rates needed to rein in inflation. In this vein,
Quantta Analytics collaborates with NITI Aayog to predict GDP growth rate of Ind …
Traditionally released by the Central Statistical Office (CSO) of the Government of India, Quantta has used its extensive database on the Indian Economy to provide an advance signal to senior leaders in Government about the state of the economy. Using data from several sectors, that drive growth, it predicted a First Quarter growth rate of 7.83% indicating that the Indian Economy is firing on all cylinders. The actual numbers released
IATA's CEIV-Pharma Certification or HSA's GDP Certification?
Players throughout the pharmaceutical supply chain are experiencing growing pressure to gain accreditation for handling the high-value, temperature-sensitive cargo, as having a certification becomes more commonplace, rather than an exceptional feat in the industry. There are currently 2 different measures of standards, one is IATA's CEIV-Pharma Certification and the other is HSA's GDP Certification. There are major players on both sides of the fence which hold – GDP-compliant certificates and CEIV-pharma certifications.
European GDP Association nominates new Advisory Board Member
So far the Board of the European GDP Association comprised four members from the industry side, supported by a representative from the Finnish Medicines Agency FIMEA. Now a new Board Member has been nominated on the industry side. Dr Laura Ribeiro, who is a Responsible Person at ID Logistics (formerly Logiters) in Portugal, has recently accepted her nomination as the fifth member of the GDP Association's Board. Prior to her
US GDP Up 1.7% Shattering Economists Predictions
Aug. 01, 2013 - HONG KONG -- On Wednesday the US Commerce Department released its highly anticipated report on GDP, stating that in the second quarter the US economy grew 1.7% driven by an increase of 1.8% in consumer spending and 9% in business investment. New home construction was another important driver of growth, with investment rising 13.4%, the fourth consecutive increase. This gain beat expectations of a 1%
Taiwan's GDP growth to hit fastest pace in 21 years
By Audrey Wang The Economist Intelligence Unit expects Taiwan’s gross domestic product to grow by 9.2 percent in 2010, the fastest rate in 21 years, according to the Council for Economic Planning and Development Sept. 24. The EIU report noted that Taiwan’s economy grew by an average of 13.1 percent in the first two quarters of 2010. This stellar performance, the EIU said, “largely reflects the global economy’s return to